Inventor · disambiguated record
Kollol Pal
Also filed as: PAL KOLLOL
13 granted patents·11 pending applications·214 citations·filing 1994–2023
91Inventor score
Files withPYRAMID BIOSCIENCES INC5BOEHRINGER INGELHEIM PHARMA4SATORI PHARMACEUTICALS INC3CORBUS PHARMACEUTICALS INC1COTTAREL GUILLAUME1
Top patents by PatentIndex Score
24 records- 0195US5733920AInhibitors of cyclin dependent kinasesMITOTIX INC·Filed 1995·Granted Mar 31, 1998·112 cites·37 claims
- 0289US11739096B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo [1,5-A]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2022·Granted Aug 29, 2023·1 cites·2 claims
- 0384US7851641B2Compounds useful for treating neurodegenerative disordersSATORI PHARMACEUTICALS INC·Filed 2006·Granted Dec 14, 2010·11 cites·18 claims
- 0484US6423519B1Compositions and methods for inhibiting fungal growthGPC BIOTECH INC·Filed 1998·Granted Jul 23, 2002·60 cites·39 claims
- 0581US11230546B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2018·Granted Jan 25, 2022·2 cites·20 claims
- 0681US9155792B2RecA inhibitors with antibiotic activity, compositions and methods of useCOTTAREL GUILLAUME·Filed 2007·Granted Oct 13, 2015·16 cites·13 claims
- 0780US7652029B2Therapeutic compound and treatmentsMEDISYN TECHNOLOGIES INC·Filed 2005·Granted Jan 26, 2010·3 cites·11 claims
- 0879US12486276B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2023·Granted Dec 2, 2025·0 cites·6 claims
- 0970US2022235055A15-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo [1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1067US8088785B2Therapeutic compound and treatmentsLLOMPART JAVIER·Filed 2009·Granted Jan 3, 2012·2 cites·9 claims
- 1154US2013338220A1Compositions, dosages, and methods of using tetrahydrocannabinol derivativesTEPPER MARK·Filed 2011·Application pending·0 cites
- 1253US2017022179A1Compositions, dosages, and methods of using tetrahydrocannabinol derivativesCORBUS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1351US2024092778A1Topical pharmaceutical compositions and methodsPYRAMID BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1449US2004266732A1Therapeutic agents, methods, and treatmentsFiled 2004·Application pending·0 cites
- 1547US5602113APyridobenzo- and pyridiothieno-diazepines useful for the treatment of HIV infectionBOEHRINGER INGELHEIM PHARMA·Filed 1994·Granted Feb 11, 1997·3 cites·5 claims
- 1647US2010234348A1Compositions and methods for potentiating antibiotic activityUNIV BOSTON·Filed 2007·Application pending·0 cites
- 1745US2011136749A1Compounds useful for treating neurodegenerative disordersSATORI PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1845US2011136750A1Compounds useful for treating neurodegenerative disordersSATORI PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1940US2002183249A1Method of identifying inhibitors of CDC25Filed 2001·Application pending·0 cites
- 2039US5594008APyrrolidine derivatives inhibitors of leukotriene biosynthesisBOEHRINGER INGELHEIM PHARMA·Filed 1994·Granted Jan 14, 1997·3 cites·9 claims
- 2137US5593979APyridobenzo-and pyridiothieno-diazepines useful for the treatment of HIV infectionBOEHRINGER INGELHEIM PHARMA·Filed 1994·Granted Jan 14, 1997·1 cites·4 claims
- 2236US2002077491A1Methods for forming combinatorial libraries combining amide bond formation with epoxide openingFiled 2001·Application pending·0 cites
- 2335US2002115106A1Methods for forming combinatorial libraries using reductive aminationNEOGENESIS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 2431US5550117ADipyrido[3,2-B:2 ',3'-E][1,4]Diaqzepines and their use in the treatment of HIV infectionBOEHRINGER INGELHEIM PHARMA·Filed 1994·Granted Aug 27, 1996·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →